1. Wray S. Modelling neurodegenerative disease using brain organoids. Semin Cell Dev Biol. 2021;111:60-6. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
2. Zhu J, Dou S, Jiang Y, Chen J, Wang C, Cheng B. Apelin-13 protects dopaminergic neurons in MPTP-induced Parkinson's disease model mice through inhibiting endoplasmic reticulum stress and promoting autophagy. Brain Res. 2019;1715:203-12. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
3. Budelier MM, Bateman RJ. Biomarkers of Alzheimer Disease. J Appl Lab Med. 2020;5(1):194-208. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
4. Chen Z-R, Huang J-B, Yang S-L, Hong F-F. Role of Cholinergic Signaling in Alzheimer's Disease. Molecules. 2022;27(6):1816. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
5. Tang KS. The cellular and molecular processes associated with scopolamine-induced memory deficit: A model of Alzheimer's biomarkers. Life Sci. 2019;233:116695. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
6. 2020 Alzheimer's disease facts and figures. Alzheimers Dement. 2020;16(3):391-460. [
View at Publisher] [
DOI] [
PMID]
7. Terranova JI, Ogawa SK, Kitamura T. Adult hippocampal neurogenesis for systems consolidation of memory. Behav Brain Res. 2019;372:112035. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
8. Puzzo D, Fiorito J, Purgatorio R, Gulisano W, Palmeri A, Arancio O, et al. Chapter 1 - Molecular Mechanisms of Learning and Memory**The authors declare no competing financial interests. In: Lazarov O, Tesco G, editors. Genes, Environment and Alzheimer's Disease. San Diego: Academic Press; 2016. p. 1-27. [
View at Publisher] [
DOI] [
Google Scholar]
9. Kumar A, Singh A, Ekavali. A review on Alzheimer's disease pathophysiology and its management: an update. Pharmacol Rep. 2015;67(2):195-203. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
10. Ulep MG, Saraon SK, McLea S. Alzheimer Disease. The Journal for Nurse Practitioners. 2018;14(3):129-35. [
View at Publisher] [
DOI] [
Google Scholar]
11. Derby CA. Trends in the public health significance, definitions of disease, and implications for prevention of Alzheimer's disease. Curr Epidemiol Rep. 2020;7(2):68-76. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
12. Esposito Z, Belli L, Toniolo S, Sancesario G, Bianconi C, Martorana A. Amyloid β, glutamate, excitotoxicity in Alzheimer's disease: are we on the right track? CNS Neurosci Ther. 2013;19(8):549-55. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
13. DeTure MA, Dickson DW. The neuropathological diagnosis of Alzheimer's disease. Mol Neurodegener. 2019;14(1):32. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
14. Roth KA. Caspases, apoptosis, and Alzheimer disease: causation, correlation, and confusion. J Neuropathol Exp Neurol. 2001;60(9):829-38. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
15. Onyango IG, Jauregui GV, Čarná M, Bennett Jr JP, Stokin GB. Neuroinflammation in Alzheimer's disease. Biomedicines. 2021;9(5):524. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
16. Masoumi J, Abbasloui M, Parvan R, Mohammadnejad D, Pavon-Djavid G, Barzegari A, et al. Apelin, a promising target for Alzheimer disease prevention and treatment. Neuropeptides. 2018;70:76-86. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
17. Aminyavari S, Zahmatkesh M, Khodagholi F, Sanati M. Anxiolytic impact of Apelin-13 in a rat model of Alzheimer's disease: Involvement of glucocorticoid receptor and FKBP5. Peptides. 2019;118:170102. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
18. Lv SY, Chen WD, Wang YD. The Apelin/APJ System in Psychosis and Neuropathy. Front Pharmacol. 2020;11:320. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
19. Zhou JX, Shuai NN, Wang B, Jin X, Kuang X, Tian SW. Neuroprotective gain of Apelin/APJ system. Neuropeptides. 2021;87:102131. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
20. Zhang Y, Jiang W, Sun W, Guo W, Xia B, Shen X, et al. Neuroprotective Roles of Apelin-13 in Neurological Diseases. Neurochem Res. 2023:48(6):1648-62. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
21. Xin Q, Cheng B, Pan Y, Liu H, Chen J, Bai B. Neuroprotective effects of apelin-13 on experimental ischemic stroke through suppression of inflammation. Peptides. 2015;63:55-62. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
22. Zhu J, Gao W, Shan X, Wang C, Wang H, Shao Z, et al. Apelin-36 mediates neuroprotective effects by regulating oxidative stress, autophagy and apoptosis in MPTP-induced Parkinson's disease model mice. Brain Res. 2020;1726:146493. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
23. Wan T, Fu M, Jiang Y, Jiang W, Li P, Zhou S. Research Progress on Mechanism of Neuroprotective Roles of Apelin-13 in Prevention and Treatment of Alzheimer's Disease. Neurochem Res. 2022;47(2):205-17. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
24. Antushevich H, Wójcik M. Review: Apelin in disease. Clin Chim Acta. 2018;483:241-8. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
25. Yildiz Z, Eren N, Orcun A, Münevver Gokyigit F, Turgay F, Gündogdu Celebi L. Serum apelin-13 levels and total oxidant/antioxidant status of patients with Alzheimer's disease. Aging Med (Milton). 2021;4(3):201-5. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
26. Wan T, Fu M, Jiang Y, Jiang W, Li P, Zhou S. Research progress on mechanism of neuroprotective roles of Apelin-13 in prevention and treatment of Alzheimer's disease. Neurochem Res. 2022:47(2):205-17. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
27. Luo H, Xiang Y, Qu X, Liu H, Liu C, Li G, et al. Apelin-13 suppresses neuroinflammation against cognitive deficit in a streptozotocin-induced rat model of Alzheimer's disease through activation of BDNF-TrkB signaling pathway. Front Pharmacol. 2019;10:395. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
28. Paul J. Chapter 5 - Experimental Medicine Approaches in CNS Drug Development. In: Nomikos GG, Feltner DE, editors. Handbook of Behavioral Neuroscience.US: Elsevier; 2019. Vol 29. p 63-80. [
View at Publisher] [
DOI] [
Google Scholar]
29. Haghparast E, Esmaeili-Mahani S, Abbasnejad M, Sheibani V. Apelin-13 ameliorates cognitive impairments in 6-hydroxydopamine-induced substantia nigra lesion in rats. Neuropeptides. 2018;68:28-35. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
30. Folch J, Petrov D, Ettcheto M, Abad S, Sánchez-López E, García ML, et al. Current Research Therapeutic Strategies for Alzheimer's Disease Treatment. Neural Plast. 2016;2016:8501693. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
31. Aminyavari S, Zahmatkesh M, Farahmandfar M, Khodagholi F, Dargahi L, Zarrindast MR. Protective role of Apelin-13 on amyloid β25-35-induced memory deficit; Involvement of autophagy and apoptosis process. Prog Neuropsychopharmacol Biol Psychiatry. 2019;89:322-34. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
32. Eren N, Den Z, Yildiz Z, Go N, Gu L, Karabiyik T. P200-levels of Apelin-13 and total oxidant/antioxidant status in sera of Alzheimer patients. Turkish Journal of Biochemistry/Turk Biyokimya Dergisi. 2012;37(S1):341. [
View at Publisher] [
Google Scholar]
33. Luo H, Han L, Xu J. Apelin/APJ system: a novel promising target for neurodegenerative diseases. J Cell Physiol. 2020;235(2):638-57. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
34. Samandari-Bahraseman MR, Elyasi L. Apelin-13 protects human neuroblastoma SH-SY5Y cells against amyloid-beta induced neurotoxicity: Involvement of anti oxidant and anti apoptotic properties. J Basic Clin Physiol Pharmacol. 2021;33(5):599-605. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
35. Chen P, Wang Y, Chen L, Song N, Xie J. Apelin-13 protects dopaminergic neurons against rotenone-induced neurotoxicity through the AMPK/mTOR/ULK-1 mediated autophagy activation. Int J Mol Sci. 2020;21(21):8376. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
36. Niknazar S, Abbaszadeh H-A, Peyvandi H, Rezaei O, Forooghirad H, Khoshsirat S, et al. Protective effect of [Pyr1]-apelin-13 on oxidative stress-induced apoptosis in hair cell-like cells derived from bone marrow mesenchymal stem cells. Eur J Pharmacol. 2019;853:25-32. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
37. Khaledi S, Ahmadi S. Amyloid Beta and Tau: from Physiology to Pathology in Alzheimer's Disease. The Neuroscience Journal of Shefaye Khatam. 2016;4(4):67-88. [
View at Publisher] [
DOI] [
Google Scholar]
38. Respekta N, Pich K, Dawid M, Mlyczyńska E, Kurowska P, Rak A. The Apelinergic System: Apelin, ELABELA, and APJ Action on Cell Apoptosis: Anti-Apoptotic or Pro-Apoptotic Effect? Cells. 2022;12(1):150. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
39. Zeng X, Yu SP, Taylor T, Ogle M, Wei L. Protective effect of apelin on cultured rat bone marrow mesenchymal stem cells against apoptosis. Stem Cell Res. 2012;8(3):357-67. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
40. Wang D, Wang Y, Shan M, Chen J, Wang H, Sun B, et al. Apelin receptor homodimer inhibits apoptosis in vascular dementia. Exp Cell Res. 2021;407(1):112739. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
41. Xu W, Li T, Gao L, Zheng J, Yan J, Zhang J, et al. Apelin-13/APJ system attenuates early brain injury via suppression of endoplasmic reticulum stress-associated TXNIP/NLRP3 inflammasome activation and oxidative stress in a AMPK-dependent manner after subarachnoid hemorrhage in rats. J Neuroinflammation. 2019;16(1):247. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
42. Liu Y, Zhang T, Wang Y, Wu P, Li Y, Wang C, et al. Apelin-13 attenuates early brain injury following subarachnoid hemorrhage via suppressing neuronal apoptosis through the GLP-1R/PI3K/Akt signaling. Biochem Biophys Res commun. 2019;513(1):105-11. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
43. Zhang L, Li F, Su X, Li Y, Wang Y, Fang R, et al. Melatonin prevents lung injury by regulating apelin 13 to improve mitochondrial dysfunction. Exp Mol Med. 2019;51(7):1-12. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
44. Chen WN, Yeong KY. Scopolamine, a Toxin-Induced Experimental Model, Used for Research in Alzheimer's Disease. CNS Neurol Disord Drug Targets. 2020;19(2):85-93. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
45. Safar MM, Arab HH, Rizk SM, El-Maraghy SA. Bone Marrow-Derived Endothelial Progenitor Cells Protect Against Scopolamine-Induced Alzheimer-Like Pathological Aberrations. Mol Neurobiol. 2016;53(3):1403-18. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
46. Bajo R, Pusil S, López ME, Canuet L, Pereda E, Osipova D, et al. Scopolamine effects on functional brain connectivity: a pharmacological model of Alzheimer's disease. Sci Rep. 2015;5(1):9748. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]
47. Gazmeh S, Azhir M, Elyasi L, Jahanshahi M, Nikmahzar E, Jameie SB. Apelin-13 protects against memory impairment and neuronal loss, Induced by Scopolamine in male rats. Metab Brain Dis. 2022;37(3):701-9. [
View at Publisher] [
DOI] [
PMID] [
Google Scholar]